Protecting Precision Healthcare: FDA and CISA Collaborate to Mitigate Software Risks in Genomic Devices
The US Food and Drug Administration (FDA) has released a statement urging healthcare providers and laboratory personnel to take necessary actions to mitigate cybersecurity risks in Illumina’s sequencing instruments. The FDA’s alert comes after…
Continue Reading